EBS obtains rights to Hikma's Kloxxado naloxone spray
Emergent BioSolutions (NYSE:EBS) has entered into an agreement for the exclusive commercial rights in the U.S. and Canada for Hikma's opioid overdose product Kloxxado. Kloxxado is a 8mg naloxone nasal spray product used for the emergency treatment of known or suspected opioid overdoses.
Emergent BioSolutions Gains Exclusive Commercial Rights to KLOXXADO® (naloxone HCI) Nasal Spray from Hikma Pharmaceuticals
Alongside over-the-counter NARCAN® Nasal Spray 4 mg, prescription KLOXXADO® (naloxone HCl) Nasal Spray 8 mg will expand Emergent’s ability to
Hikma announces exclusive commercial partnership with Emergent BioSolutions for KLOXXADO® (naloxone HCl) nasal spray 8 mg
Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical group, today announces that it has entered an exclusive commercial partnership with Emergent BioSolutions (Emergent) for the sale of KLOXXADO® naloxone HCl nasal spray 8 mg in the U.
Emergent BioSolutions, Hikma enter partnership for sale of Kloxxado nasal spray
Hikma Pharmaceuticals (HKMPF) announces that it has entered an exclusive commercial partnership with Emergent BioSolutions (EBS) for the sale of
Hikma Pharma Inks Exclusive Commercial Deal With Emergent BioSolutions For KLOXXADO Nasal Spray 8 Mg
Hikma Pharmaceuticals plc (HIK, HIK.L) announced Tuesday that it has entered an exclusive commercial partnership with Emergent
Women's Health Aus21h
So, what’s the ‘Barbie drug’, exactly?
Seeing nasal tanning spray doing the rounds? Here's what it is and why you should be avoiding it, per experts.
Urgent warning over illegal ‘Barbie drug’ TikTok trend
Doctors are warning about the far-reaching effects of a tanning spray such as kidney problems and increased skin cancer risk.
Illegal tanning nasal spray not a 'harmless alternative' to sunbaking, says TGA
Nasal tanning sprays are illegal and can cause serious side effects according to Australia's drug and medical device watchdog ...